Business
Digipath Obtains Health Canada R&D License for Cannabis Strain Development and Sales
Digipath Obtains Health Canada R&D License for Cannabis Strain Development and Sales.
About this update from Hypha Labs, Inc.
[{"type":"text","content":"\n License Comes Via Recent Acquisition of VSSL Enterprises Ltd. LAS VEGAS, NV, March 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a leading independent analytical testing laboratory, data analytics and technology firm focused on the cannabis and hemp markets, is pleased to report that it has received a Research and Development license to cultivate cannabis via an approval provided by Health Canada to the Company’s recently acquired VSSL Enterprises Ltd. VSSL’s management team, including Kyle Remenda and Dr. Philippe Henry have joined Digipath’s management team as CEO and Chief Technology Officer, respectively. The Research and Development (R&D) license will enable the Company to cultivate cannabis at three field sites with 2,000 plants at a time per site, and one lab where the genetics can be grown via tissue culture. Digipath will use the R&D license to focus on stabilizing prized elite genetics and developing novel cannabis genetics using a combination of standard breeding and biotech tools. Once the Company has developed something novel, characterized imported seeds, or improved on existing genetics, the Company can apply to Health Canada for a sales amendment to sell the product of its R&D in legal markets.   “We are pleased to have secured the permission from Health Canada and to expand Digipath’s efforts internationally,” stated Kyle Remenda, CEO, Digipath, Inc. “We can combine the experience and knowledge bases of VSSL and Digipath to pursue the opportunity with greater vigor and to greatly expand future opportunities for the Company and to the benefit of its shareholders.” “I would also like to remind our shareholders that we continue to support the Nevada cannabis industry with testing and quality control as they are permitted to sell via delivery services through Nevada’s temporary shutdown of non-essential businesses,” added Remenda. About Digipath, Inc. (OTCQB: DIGP) Digipath, Inc., supports the cannabis industry’s best practices for reliable testing, data acquisition, and new canna-tech for the cannabis industry. Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, con...